There Is No Change Without Scale: How Chinese Deep-Tech Scales Up Globally with Rémi Petitfrere

Join Rémi Petitfrere, Global Vice President and Head of Strategy at SynMetabio, for an insightful masterclass on taking frontier deep-tech out of the laboratory and scaling it into a market-dominant global industry. While the Western tech ecosystem excels at early-stage concept validation and venture marketing, the transition from "promising startup" to high-volume commercial production often falters at the scale-up stage. Drawing on over two decades of cross-border executive experience between Europe and China—including C-level leadership at EHang through its 2019 Nasdaq IPO, leadership roles at Volocopter, and cross-border investment advisory—Rémi demonstrates why manufacturing capacity, unit economics, and supply chain integration matter far more than theoretical technological novelty.🎯 Insights You’ll Learn:There Is No Change Without Scale: Why breakthrough technologies must surpass the "cute sustainable startup" narrative to directly compete on cost, volume, and performance with legacy petrochemical and chemical industries.The China-to-Global Scaling Playbook: How leveraging Chinese industrial manufacturing speed, supply chain density, and mass-production infrastructure accelerates global market penetration.Industrializing Mycelium-Based Biomaterials: Inside SynMetabio’s transition from fungal bio-fabrication R&D to multi-ton automated fermentation and bio-based synthetic leather production.Cross-Border Market Execution: Navigating the cultural, regulatory, and commercial bridges required to launch Chinese deep-tech innovations across European and Western enterprise markets.Lessons from the eVTOL & AI Frontiers: Strategic takeaways from leading advanced air mobility ventures like EHang and Volocopter through capital raises, public market debuts (Nasdaq), and global commercialization.The Path to Public Markets: Structuring a deep-tech biotech startup’s balance sheet, unit economics, and operational growth for future public listings and global equity markets.🌍 Why This Matters:The global energy and materials transition cannot rely on niche, premium-priced eco-products that only appeal to conscious consumers. To replace oil-derived plastics, synthetic leathers, and carbon-intensive materials, bio-manufactured alternatives must achieve massive industrial throughput at price parity. Rémi Petitfrere and the leadership team at SynMetabio are proving how Chinese manufacturing power and synthetic biology converge to solve this challenge. By combining scaled bio-fermentation with global market strategy, SynMetabio is transforming sustainable biomaterials into a serious, high-volume industrial sector capable of displacing traditional chemical incumbents.👤 Expert Background:Global Vice President & Head of Strategy at SynMetabio, driving international expansion, strategic partnerships, and commercial scale-up for next-generation mycelium biomaterials.Former C-Level Executive at EHang, where he participated in the autonomous aerial vehicle pioneer's landmark Nasdaq IPO in December 2019.Former Advanced Air Mobility Leader, having held key strategic roles at Volocopter and across urban AI/eVTOL ventures.🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.💡 Perfect For:Deep-tech investors, synthetic biology leaders, industrial supply chain directors, venture capital partners, cross-border strategy executives, and materials science innovators looking to scale hardware and biotech startups globally.Subscribe for more global founder conversations from GSD Venture Studios: https://gsdvs.com#DeepTech #SyntheticBiology #SynMetabio #Biomaterials #ChinaInnovation #ScaleUp #GlobalStrategy #RemiPetitfrere #GaryFowler #GSDVentureStudios